Essex Biotechnology Secures Exclusive Global Rights and Interests of SkQ1 in the field Ophthalmology from Mitotech
HONG KONG, Oct 13, 2022 – (ACN Newswire via SEAPRWire.com) – Essex Bio-Technology Limited (the “Company”, together with its subsidiaries, the “Group”) wishes to announce that Essex Bio-Investment Limited (“Essex Bio-Investment”), a wholly-owned subsidiary of the Group has on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent... » read more